Matches in Wikidata for { <http://www.wikidata.org/entity/Q87708735> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q87708735 description "article scientifique publié en 2014" @default.
- Q87708735 description "artículu científicu espublizáu en febreru de 2014" @default.
- Q87708735 description "im Februar 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87708735 description "scientific article published on 22 February 2014" @default.
- Q87708735 description "wetenschappelijk artikel" @default.
- Q87708735 description "наукова стаття, опублікована в лютому 2014" @default.
- Q87708735 name "Re: β3-adrenoreceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men" @default.
- Q87708735 name "Re: β3-adrenoreceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men" @default.
- Q87708735 type Item @default.
- Q87708735 label "Re: β3-adrenoreceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men" @default.
- Q87708735 label "Re: β3-adrenoreceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men" @default.
- Q87708735 prefLabel "Re: β3-adrenoreceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men" @default.
- Q87708735 prefLabel "Re: β3-adrenoreceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men" @default.
- Q87708735 P1433 Q87708735-837B809D-BF03-4DCE-9402-FEA933DBBC5E @default.
- Q87708735 P1476 Q87708735-AF433152-45A0-4344-B24E-75037D4EDEC6 @default.
- Q87708735 P304 Q87708735-C5DF06EF-BC46-483C-82F6-F068065E2C28 @default.
- Q87708735 P31 Q87708735-28105347-90D4-41E8-98FD-5F7603E93DDC @default.
- Q87708735 P356 Q87708735-80A143FC-4F87-497B-B88E-2C420C8F6F4B @default.
- Q87708735 P433 Q87708735-46EBFBC6-A35F-4328-A87F-68736CA18CD3 @default.
- Q87708735 P478 Q87708735-92F1CC84-05FB-41F3-8066-105E2600FF29 @default.
- Q87708735 P50 Q87708735-73166263-486E-4FD7-B3BA-7FE99E481330 @default.
- Q87708735 P577 Q87708735-3B052DF8-4BF1-4CC0-8D65-AF59CA71C127 @default.
- Q87708735 P698 Q87708735-EA7F5D9F-4FEE-4AFF-9925-13F6D59F9C1F @default.
- Q87708735 P921 Q87708735-103D2920-E382-47C6-B18A-AEF8C314FD07 @default.
- Q87708735 P356 J.JURO.2014.02.067 @default.
- Q87708735 P698 24745510 @default.
- Q87708735 P1433 Q15709979 @default.
- Q87708735 P1476 "Re: β3-adrenoreceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men" @default.
- Q87708735 P304 "1344-1346" @default.
- Q87708735 P31 Q13442814 @default.
- Q87708735 P356 "10.1016/J.JURO.2014.02.067" @default.
- Q87708735 P433 "5" @default.
- Q87708735 P478 "191" @default.
- Q87708735 P50 Q88176270 @default.
- Q87708735 P577 "2014-02-22T00:00:00Z" @default.
- Q87708735 P698 "24745510" @default.
- Q87708735 P921 Q506659 @default.